Literature DB >> 23013144

Copper bromide laser for facial telangiectasia: a dose response evaluation.

William R Owen1, Elaine Hoppe.   

Abstract

Facial telangiectases are small dilated vessels that are visible on the skin surface. They are a cosmetic disfigurement for millions of people, making their treatment one of the most frequently requested procedures in dermatology. Several treatment choices are available, including a variety of lasers. The purpose of this study was to evaluate the results, using a copper bromide laser, of variable energy levels related to vessel size and location, including side effects, and to survey patient assessment of benefit and tolerance. Two groups of 19 patients were treated at 23 J/cm(2) and 28 J/cm(2) , and 32 J/cm(2) and 38 J/cm(2) , respectively. Only facial telangiectasias were treated. Benefit was seen at all energy settings. Little additional benefit was noted with energy increase alone, but it was noted with a second treatment. This study showed that the copper bromide laser is a very effective, safe, and well tolerated treatment for facial telangiectasia at all four tested energy levels.
© 2012 The Authors. Australasian Journal of Dermatology © 2012 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013144     DOI: 10.1111/j.1440-0960.2012.00948.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  2 in total

1.  Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series.

Authors:  Yelda Kapicioglu; Gulbahar Sarac; Hulya Cenk
Journal:  Lasers Med Sci       Date:  2018-08-10       Impact factor: 3.161

2.  Successful Treatment of Reticular Blue Veins of the Lower Eyelid by Long-Pulse Nd: YAG - Case Report with 8-Year Follow-Up.

Authors:  Alberto Goldman; Torello Lotti; Georgi Tchernev; Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2017-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.